LYBE SCIENTIFIC AS

Operating

Å utvikle og tilby ulike løsninger for prøvepreparering og analyse innenfor diagnostikkformål.

Å utvikle og tilby ulike løsninger innenfor sample prep, herunder nukleinsyreekstraksjonsløsninger samt analysemetoder for diagnostikkformål.

Organization

CEO: TS
Tonje Strømmen Steigedal1979
Chairman of the board: MW
Mårten Wigstøl1960
Years since formation: 5 years; since Mar 3, 2021
Type: Limited company
VAT registered: Yes
Number of employees: 5

Ownership

Number of shares and share classes: 175,573; 1 share class
Total number of shareholders: 17; 11 companies, 6 persons

Financials

Total operating income 2025: 3,550,849; NOK
Annual total result 2025: -294,559; NOK

Last update: Jul 28, 2026

Management

Management / administration

Name	Role	Shares
TS Tonje Strømmen Steigedal 1979	Managing Director/CEO	-

Board

Name	Role	Shares
MW Mårten Wigstøl 1960	Chairman	-
SB Sulalit Bandyopadhyay 1988	Board Member	-
GØ Gisle Østereng 1981	Board Member	-

Others

Name	Role	Shares
B BDO AS	Auditor	-
E ENORA AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
SS Strømmen Steigedal Tonje 1979	-	9.16 % indirectly
BM Bjørås Magnar 1965	-	7.8 % directly
ØA Østvik Asgeir 1963	-	6.9 % indirectly
BS Bandyopadhyay Sulalit 1988	-	6.5 % indirectly
GØ Grotmol Øyvind 1980	-	4.83 % indirectly
WM Wigstøl Mårten 1960	-	4.2 % indirectly
AG Aasland Grotmol Lars 1983	-	3.56 % indirectly
EE Even Erlandsen Sten 1978	-	3.53 % directly
AA Arne Aas Per 1971	-	3.25 % directly
SA Sharma Anuvansh 1991	-	1.95 % directly

Last update: Aug 25, 2026

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
L LYBE SCIENTIFIC AS	Ordinary shares	28,000	15.95 %
S STARTUPLAB FOUNDERS FUND IV AS	Ordinary shares	22,728	12.95 %
A ALACRIS AS	Ordinary shares	16,086	9.16 %
BM Bjørås Magnar 1965	Ordinary shares	13,694	7.8 %
N NTNU TECHNOLOGY TRANSFER AS	Ordinary shares	13,000	7.4 %
Y YSTVIKA HOLDING AS	Ordinary shares	12,122	6.9 %
I ISO INVEST AS	Ordinary shares	11,412	6.5 %
G GROTMOL SOLUTIONS AS	Ordinary shares	8,333	4.75 %
T TIDLIGFASEFONDET AS Closed	Ordinary shares	8,333	4.75 %
B BARRACUDA INVEST AS	Ordinary shares	7,373	4.2 %
A ANDVARI INVESTMENT RESEARCH AS	Ordinary shares	6,250	3.56 %
EE Even Erlandsen Sten 1978	Ordinary shares	6,206	3.53 %
G GNIST CAPITAL AS	Ordinary shares	6,061	3.45 %
AA Arne Aas Per 1971	Ordinary shares	5,706	3.25 %
HL Hagen Lars 1975	Ordinary shares	3,423	1.95 %
SA Sharma Anuvansh 1991	Ordinary shares	3,423	1.95 %
OV Ottesen Vegar 1981	Ordinary shares	3,423	1.95 %

Shares owned by the LYBE SCIENTIFIC AS

Name	Share class	Total number of shares	Share
L LYBE SCIENTIFIC AS	Ordinary shares	28,000	15.95 %

Last update: Sep 25, 2026

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	3,550,849	4,937,610	2,147,701	6,228,552	14,976,818
Annual Total Result	-294,559	87,041	-2,559,171	-709,976	2,500,125
Total assets	0	17,765,313	12,891,592	10,915,258	5,313,476
Total liabilities	0	8,923,153	7,690,950	9,015,109	2,703,351
Total equity	0	8,842,159	5,200,642	1,900,149	2,610,125

P&L

Year	2025	2024	2023	2022	2021
Total operating income	3,550,849	4,937,610	2,147,701	6,228,552	14,976,818
Total operating costs	3,322,405	4,435,287	4,502,825	7,026,094	11,765,775
Operating result	228,444	502,322	-2,355,124	-797,542	3,211,043
Financial income/costs	-523,002	-415,281	-27,526	-103,190	-5,611
Profit before tax	-294,559	87,041	-2,382,650	-900,732	3,205,432
Total tax & extraordinary income/cost	0	0	176,521	-190,756	705,307
Annual Total Result	-294,559	87,041	-2,559,171	-709,976	2,500,125

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	10,156,386	5,803,417	2,978,561	831,160
Total current assets	7,608,926	7,088,175	7,936,697	4,482,316
Total assets	17,765,313	12,891,592	10,915,258	5,313,476
Short term debt	5,256,489	4,140,828	4,438,634	1,989,116
Long term debt	3,666,664	3,550,122	4,576,475	714,235
Total liabilities	8,923,153	7,690,950	9,015,109	2,703,351
Contributed capital	8,931,889	5,377,413	110,000	110,000
Retained earnings	-89,730	-176,771	1,790,149	2,500,125
Total equity	8,842,159	5,200,642	1,900,149	2,610,125
Total equity and liabilities	17,765,313	12,891,592	10,915,258	5,313,476

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

LYBE SCIENTIFIC AS926 682 520